CTLA4 and melanoma: In order to assess for a humoral memory response, we collected serum from mice cured of B78 melanoma by an RT + IT-IC + anti-CTLA-4 in situ vaccine regimen and subsequently demonstrated immune memory by rejection of subcutaneous re-engraftment of B78 cells 90 days after treatment.